Literature DB >> 16995875

Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.

Md Zahidunnabi Dewan1, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto.   

Abstract

Natural killer (NK) cells are an important component of the innate immune response against microbial infections and tumors. Direct involvement of NK cells in tumor growth and infiltration has not yet been demonstrated clearly. Primary effusion lymphoma (PEL) cells were able to produce tumors and ascites very efficiently with infiltration of cells in various organs of T-, B- and NK-cell knock-out NOD/SCID/gammac(null) (NOG) mice within 3 weeks. In contrast, PEL cells formed small tumors at inoculated sites in T- and B-cell knock-out NOD/SCID mice with NK-cells while completely failing to infiltrate into various organs. Immunosupression of NOD/SCID by treatment with an antimurine TM-beta1 antibody, which transiently abrogates NK cell activity in vivo, resulted in enhanced tumorigenicity and organ infiltration in comparison with non-treated NOD/SCID mice. Activated human NK cells inhibited tumor growth and infiltration in NOG mice. Our results suggest that NK cells play an important role in growth and infiltration of PEL cells, and activated NK cells could be a promising immunotherapeutic tool against tumor or virus-infected cells either alone or in combination with conventional therapy. The rapid and efficient engraftment of PEL cells in NOG mice also suggests that this new animal model could provide a unique opportunity to understand and investigate the mechanism of pathogenesis and malignant cell growth.

Entities:  

Mesh:

Year:  2006        PMID: 16995875     DOI: 10.1111/j.1349-7006.2006.00319.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  6 in total

1.  Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge.

Authors:  Amanda Kwant-Mitchell; Elishka A Pek; Kenneth L Rosenthal; Ali A Ashkar
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

2.  Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.

Authors:  Hiroki Goto; Yuki Kojima; Hirokazu Nagai; Seiji Okada
Journal:  Int J Hematol       Date:  2013-04-21       Impact factor: 2.490

3.  Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.

Authors:  Baskar Subramani; Chithra Ramanathan Pullai; Kohila Krishnan; Sheela Devi Sugadan; Xuewen Deng; Terunuma Hiroshi; Kananathan Ratnavelu
Journal:  Biomed Rep       Date:  2014-03-26

4.  Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors.

Authors:  Tsutomu Nakazawa; Takayuki Morimoto; Ryosuke Maeoka; Ryosuke Matsuda; Mitsutoshi Nakamura; Fumihiko Nishimura; Shuichi Yamada; Ichiro Nakagawa; Young-Soo Park; Hiroyuki Nakase; Takahiro Tsujimura
Journal:  Regen Ther       Date:  2022-07-21       Impact factor: 3.651

5.  NK cell-based autologous immune enhancement therapy (AIET) for cancer.

Authors:  H Terunuma; X Deng; N Nishino; K Watanabe
Journal:  J Stem Cells Regen Med       Date:  2013-04-30

6.  Proceedings of the Annual Symposium & Plenary Session on Regenerative Medicine (PASRM).

Authors: 
Journal:  J Stem Cells Regen Med       Date:  2012-11-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.